AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Ascend Wellness Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $79.60M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.4278 (−52.18%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Ascend Wellness Holdings, Inc. saw revenue fall 8.4% to $488.33M over the twelve months to Jun 30, 2026. Operating income fell 306.6% to -$10.67M, moving the operating margin from 1.0% to -2.2%. Free cash flow was -$6.95M, down 118.2% from a year earlier.
Revenue
$488.33M
-8.4% vs. a year earlier
Operating income
-$10.67M
-306.6% vs. a year earlier
Free cash flow
-$6.95M
-118.2% vs. a year earlier
EPS, diluted
-$0.58
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $79.60M
- P/E ratio
- –
- Price to sales
- 0.16
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -8.73%
Fundamentals
- Revenue
- $488.33M
- EPS, diluted
- -$0.58
- Free cash flow
- -$6.95M
- Book value per share
- -$0.42
- Diluted shares
- 203M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$488.33M-8.4% YoY
Gross profit
$179.10M+4.4% YoY
Operating income
-$10.67M-306.6% YoY
Net income
–
EPS, diluted
–
Free cash flow
-$6.95M-118.2% YoY
Reported periodTrailing twelve months